Replies to post #519870 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

theorysuit,

FDA wants all eyes on them with regard to “approval” of ECAs in THIS trial. They can’t stop the forward progress being made with MHRA and most likely don’t want to but they must be very careful with how they handle NWBO and NWBO knows this too. There is big money on the line and “the process” must be followed properly to avoid legal challenge from “those not invested”. NWBO is not going to do anything to upset FDA and FDA won’t do anything to stop MHRA from moving ahead if their own process ends up being slower. NWBO let investors know that progress is being made with the PIP announcement whether they had to or not and if regulators are indeed working together then ECA acceptance by FDA can be considered a formality that can’t yet be officially disclosed which is possibly why there is so much “noise” on the message board lately. Best wishes.

[Maverick0408]

Completely in agreement with your statements.

They will PR MAA acceptance. They will be shouting from the rooftop, just watch! They actually appear desperate, shows from their PIP approval PR. Also a strong indication that MAA acceptance is far off. If it was going to be close there was no reason to PR PIP news. No one does that! The reality is they have been playing with retail all this while with their carefully crafted (ambiguous) PRs.

By the way, LG, DI, and LP are BS artists. Remember how DI and LG told posters that publication was submitted when posters reported their calls from Jan-Feb! Ashkan’s statements today confirmed that it wasn’t submitted until after NYAS presentation at the earliest.

LP said at a virtual science conference in summer 2020 that they can’t wait to reveal the unblinded data to the community in the coming weeks.

[Bob_LobLaw]

They only talk when they need retail to buy. Someone sold into that PR